Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01564641 · ClinicalTrials.gov registry record

Study of the ConforMIS iDuo(R) G2

A clinical trial, sponsored by Restor3D.

Terminated
Registry status
150
Enrollment target

NCT01564641: Clinical Trial study, sponsored by Restor3D.

NCT01564641 is a clinical trial that was terminated before completion, run by Restor3D. The registered enrollment target is 150 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01564641 was terminated before completion, sponsored by Restor3D.

TERMINATED
Registry status
150 participants
Enrollment target

Study Summary

To evaluate the ConforMIS iDuo G2 implant

Primary Outcome

By using questionnaires, we will look at pain and function scores at this time point

Interventions

  • DEVICE iDuo G2

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2012-05
Est. Completion 2022-11-18
Restor3D

20 total trials

Why NCT01564641 stopped before completion

NCT01564641 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which iDuo G2 is the first listed.

NCT01564641 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01564641 about?

NCT01564641 is a clinical study titled "Study of the ConforMIS iDuo(R) G2". To evaluate the ConforMIS iDuo G2 implant

What is the current status of trial NCT01564641?

This trial is currently terminated. The enrollment target is 150 participants. The study started on 2012-05. Estimated completion is 2022-11-18.

What interventions are being tested in trial NCT01564641?

The interventions under investigation include: iDuo G2 (DEVICE).

Who is sponsoring clinical trial NCT01564641?

This trial is sponsored by Restor3D, which has 20 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01564641, the US trial registry maintained by the National Library of Medicine. NCT01564641 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.